David Roman
Stock Analyst at Goldman Sachs
(3.65)
# 2,159
Out of 5,090 analysts
244
Total ratings
52.5%
Success rate
6.2%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Rated: Hold | $17 → $21 | $23.00 | -8.70% | 20 | Jul 15, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $17 → $19 | $16.75 | +13.43% | 7 | Jul 15, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $19 → $21 | $20.00 | +5.00% | 4 | Jul 14, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $71 → $57 | $41.98 | +35.78% | 11 | Jul 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $31 | $10.58 | +193.01% | 2 | Jul 14, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $21 → $16 | $19.11 | -16.27% | 7 | Jul 14, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $95 → $98 | $92.01 | +6.51% | 18 | Jun 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $558 | $432.01 | +29.16% | 21 | Jun 15, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $26 → $25 | $18.73 | +33.48% | 7 | Jun 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $84 → $83 | $96.54 | -14.03% | 12 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $24 | $18.28 | +31.29% | 2 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $113 | $106.20 | +6.40% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $89 → $88 | $102.47 | -14.12% | 5 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $73 → $61 | $59.55 | +2.43% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 → $205 | $149.68 | +36.96% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $8.51 | -5.99% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $237.60 | -35.61% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $32.76 | -26.74% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $82.29 | -2.78% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $19.13 | +4.55% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $73 → $72 | $78.97 | -8.83% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $50 | $32.12 | +55.67% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $14.95 | +7.02% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $54 → $66 | $81.33 | -18.85% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $357 → $361 | $291.86 | +23.69% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $76.57 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $147 | $123.37 | +19.15% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $197.88 | -15.61% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $29.69 | -42.74% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $93 → $88 | $94.52 | -6.90% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $78.05 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $119.65 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $103 | $107.94 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $44 → $15 | $7.49 | n/a | 2 | Aug 30, 2012 |
Baxter International
Jul 15, 2026
Rated: Hold
Price Target: $17 → $21
Current: $23.00
Upside: -8.70%
Beta Bionics
Jul 15, 2026
Rated: Buy
Price Target: $17 → $19
Current: $16.75
Upside: +13.43%
Bausch + Lomb
Jul 14, 2026
Reiterated: Hold
Price Target: $19 → $21
Current: $20.00
Upside: +5.00%
Boston Scientific
Jul 14, 2026
Reiterated: Buy
Price Target: $71 → $57
Current: $41.98
Upside: +35.78%
Mobia Medical
Jul 14, 2026
Reiterated: Buy
Price Target: $31
Current: $10.58
Upside: +193.01%
Tandem Diabetes Care
Jul 14, 2026
Reiterated: Hold
Price Target: $21 → $16
Current: $19.11
Upside: -16.27%
Edwards Lifesciences
Jun 15, 2026
Reiterated: Buy
Price Target: $95 → $98
Current: $92.01
Upside: +6.51%
Intuitive Surgical
Jun 15, 2026
Reiterated: Buy
Price Target: $558
Current: $432.01
Upside: +29.16%
Omada Health
Jun 10, 2026
Reiterated: Buy
Price Target: $26 → $25
Current: $18.73
Upside: +33.48%
Medtronic
Jun 4, 2026
Reiterated: Hold
Price Target: $84 → $83
Current: $96.54
Upside: -14.03%
Jun 3, 2026
Reiterated: Buy
Price Target: $14 → $24
Current: $18.28
Upside: +31.29%
May 31, 2026
Reiterated: Buy
Price Target: $121 → $113
Current: $106.20
Upside: +6.40%
May 29, 2026
Reiterated: Sell
Price Target: $89 → $88
Current: $102.47
Upside: -14.12%
May 27, 2026
Reiterated: Sell
Price Target: $73 → $61
Current: $59.55
Upside: +2.43%
May 27, 2026
Reiterated: Buy
Price Target: $237 → $205
Current: $149.68
Upside: +36.96%
May 27, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $8.51
Upside: -5.99%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $237.60
Upside: -35.61%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $32.76
Upside: -26.74%
May 15, 2026
Reiterated: Buy
Price Target: $80
Current: $82.29
Upside: -2.78%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $19.13
Upside: +4.55%
May 6, 2026
Reiterated: Hold
Price Target: $73 → $72
Current: $78.97
Upside: -8.83%
May 6, 2026
Reiterated: Buy
Price Target: $54 → $50
Current: $32.12
Upside: +55.67%
May 5, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $14.95
Upside: +7.02%
May 5, 2026
Reiterated: Sell
Price Target: $54 → $66
Current: $81.33
Upside: -18.85%
May 1, 2026
Reiterated: Hold
Price Target: $357 → $361
Current: $291.86
Upside: +23.69%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $76.57
Upside: -
Apr 30, 2026
Reiterated: Hold
Price Target: $147
Current: $123.37
Upside: +19.15%
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $197.88
Upside: -15.61%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $29.69
Upside: -42.74%
Feb 10, 2026
Reiterated: Sell
Price Target: $93 → $88
Current: $94.52
Upside: -6.90%
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $78.05
Upside: n/a
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $119.65
Upside: n/a
Nov 15, 2013
Reiterated: Sell
Price Target: $103
Current: $107.94
Upside: n/a
Aug 30, 2012
Reiterated: Hold
Price Target: $44 → $15
Current: $7.49
Upside: n/a